1. Introduction
===============

Acyclovir (ACV, 9-(2-hydroxyethoxymethyl) guanine, Zovirax \[[@B1-pharmaceuticals-07-00695],[@B2-pharmaceuticals-07-00695]\], [Figure 1](#pharmaceuticals-07-00695-f001){ref-type="fig"}), is a guanine derivative possessing antiviral activity and commonly used in the treatment of herpes. It is a potent antiviral agent that is used as a highly specific inhibitor of herpes viruses (HSV) types 1 and 2 \[[@B3-pharmaceuticals-07-00695],[@B4-pharmaceuticals-07-00695],[@B5-pharmaceuticals-07-00695],[@B6-pharmaceuticals-07-00695],[@B7-pharmaceuticals-07-00695]\]. A series of new guanine base modified tricyclic analogues of ACV and ganciclovir were evaluated for activity against herpes simplex virus type 1 and 2, showing similar antiherpetic potency as the parent compounds ACV and ganciclovir \[[@B8-pharmaceuticals-07-00695]\]. The antiherpetic activity was found to be strongly dependent on the nature and esteric demands of the substituents in the 6 and/or 7 positions \[[@B9-pharmaceuticals-07-00695]\].

![Molecular structure and definition of the torsional angles in tautomer N1 of acyclovir.](pharmaceuticals-07-00695-g001){#pharmaceuticals-07-00695-f001}

Most persons who are infected with human immunodeficiency virus type (HIV-1) are also infected with herpes simplex type2 (HSV-2), which is associated with increased plasma and genital levels of HIV-1. Thus, it has been reported that ACV inhibits HIV upon human herpes virus (HHV) coinfection in tissue cultures. This activity was found to be correlated with the phosphorylation of the parent drug to the monophosphate form mediated by HHV-encoded kinase \[[@B10-pharmaceuticals-07-00695]\]. Recent studies show that ACV decreases the HIV-1 RN and suppress both viruses in coinfected tissues \[[@B11-pharmaceuticals-07-00695]\], with great impact on HIV and HSV-2 seropositive patients \[[@B12-pharmaceuticals-07-00695],[@B13-pharmaceuticals-07-00695]\]. The treatment of ACV- resistant HSV infections \[[@B7-pharmaceuticals-07-00695],[@B14-pharmaceuticals-07-00695]\] and tests for release it at oral therapeutic levels have been also reported \[[@B15-pharmaceuticals-07-00695]\].

As it is shown above, ACV has been extensively studied from the pharmaceutical and medical point of view. However, few studies appear on its molecular structure, only at low level \[[@B16-pharmaceuticals-07-00695]\], and to our knowledge, there is no data on its conformational characteristics by Density Functional Methods (DFT) or *ab initio* quantum chemical methods. Thus, it is one of the tasks of the present manuscript. Conformations of some derivatives of ACV with biological activities have been reported \[[@B17-pharmaceuticals-07-00695]\], as well as studies of complexes of ACV with several metals \[[@B18-pharmaceuticals-07-00695],[@B19-pharmaceuticals-07-00695]\].

The tautomeric study of DNA structural components has a great interest today with numerous research publications \[[@B20-pharmaceuticals-07-00695],[@B21-pharmaceuticals-07-00695]\]. The tautomeric equilibrium in ACV between the keto and enol forms has been observed from the UV/VIS spectra \[[@B22-pharmaceuticals-07-00695]\]. This equilibrium depends on the polarity of the solvent, and therefore, in water solution the keto form prevails, while in methylene chlorides it is the enol one. Thus, another goal of the present manuscript is to study the possible tautomers of ACV, and the determination of their % populations at room temperature and at 273.15 K. The stability of these tautomers and its dependence of different parameters is another point analyzed here.

Finally, from our understanding, would be interesting to calculate the different conformational possibilities of ACV and compare the results with the natural nucleoside deoxyguanosine (dG). This is the last goal of the present manuscript. An accurate knowledge of the different conformers of ACV, its charge distribution, inter- and intra-molecular interactions, solid structure, and flexibility would be an important help for the interpretation of drug-target interactions, as well as to design new antivirus.

For this reason, the conformers of natural and analogues nucleosides have been analyzed by different authors. Now, an extensive theoretical study of the conformational preferences in ACV has been carried out with full relaxation of all geometric parameters, in an attempt to gain insights into molecular features responsible for activity. We will attempt to determine herein, if the various geometric features in ACV are correlated or interact with one another. We are also interested in whether alternative forms of hydrogen bonding make significant contributions to the conformational behavior of ACV.

2. Computational Details
========================

Calculations were carried out by using the Becke exchange functional (B) \[[@B23-pharmaceuticals-07-00695]\], Becke's three-parameter exchange functional (B3) \[[@B24-pharmaceuticals-07-00695]\], Handy's OPTX modification of Becke's exchange functional (O) \[[@B25-pharmaceuticals-07-00695],[@B26-pharmaceuticals-07-00695]\] and the extended (X3) \[[@B27-pharmaceuticals-07-00695]\], in combination with the correlation functionals of Lee, Yang, and Parr (LYP) \[[@B28-pharmaceuticals-07-00695]\], and Perdew and Wang's 1991 (PW91) \[[@B29-pharmaceuticals-07-00695]\]. B3LYP Density Functional method (DFT) is the most used today, and for this reason the majority of the calculations were carried out with it.

All the methods appear implemented in the GAUSSIAN 03 program package \[[@B30-pharmaceuticals-07-00695]\]. The UNIX version with standard parameters of this package was used in the alpha computer of the Computational Centre from University Complutense of Madrid, in which all quantum chemical computations were performed. DFT methods provide adequate compromise between the desired accuracy and the heavy demands put on computer time and power. Different studies have shown that the data obtained with DFT methods are in good agreement with those obtained by expensive computational methods as MP2 \[[@B31-pharmaceuticals-07-00695],[@B32-pharmaceuticals-07-00695],[@B33-pharmaceuticals-07-00695],[@B34-pharmaceuticals-07-00695],[@B35-pharmaceuticals-07-00695]\]. Also they give good results in many studies on nucleosides and on drug design \[[@B36-pharmaceuticals-07-00695],[@B37-pharmaceuticals-07-00695]\] and they predict vibrational frequencies of DNA bases better than HF and MP2 \[[@B38-pharmaceuticals-07-00695],[@B39-pharmaceuticals-07-00695],[@B40-pharmaceuticals-07-00695],[@B41-pharmaceuticals-07-00695],[@B42-pharmaceuticals-07-00695]\]. Moreover, because of the high size of ACV, MP2 calculations were only possible with the 6--31G(d) basis set for memory computer problems. However, we used the 6--31G(d,p) basis to calculate single point energies.

The 3D Potential Energy Surface (PES) of this molecule was determined by rotation of the exocyclic and endocyclic torsional angles φ~1~ (equivalent to χ angle in nucleosides \[[@B43-pharmaceuticals-07-00695]\]), φ~2~, φ~3~, φ~4~ and φ~5.~ These dihedral angles were simultaneously hold fixed at values varying between 0° and 360° in steps of 60° in a first study. All other geometrical parameters were relaxed during these optimizations. 78 optimized geometries were obtained in this step by minimizing the energy with respect to all geometrical parameters without imposing molecular symmetry constraints. Berny optimizations under the TIGHT criterion were used. Atomic charges were determined with the Natural NBO procedure \[[@B44-pharmaceuticals-07-00695]\].

Harmonic wavenumber computations were carried out at the same level of the respective optimization process and by the analytic evaluation of the second derivative of the energy with respect to nuclear displacement. Vibrational frequencies calculations were performed on all optimized conformers to confirm that they corresponded to local minima. All optimized structures showed only positive harmonic vibrations (local energy minima). Relative energies were obtained by adding zero-point vibrational energies (ZPEs) to the total energy. For the calculation of the ZPEs, the frequencies were retained unscaled. The Δ*G* values were sums of electronic and thermal Free Energies. The conformational equilibrium at 298.15 K was evaluated by means of the Boltzmann distribution formula exp(−Δ*G*/kT), where Δ*G* is the relative Gibbs energy.

3. Results and Discussion
=========================

ACV has five possible tautomers ([Figure 2](#pharmaceuticals-07-00695-f002){ref-type="fig"}), that were fully optimized at different levels of computation, [Table 1](#pharmaceuticals-07-00695-t001){ref-type="table"}. The most stable one corresponds to N1, and thus we have focused the study only in this tautomer. The remaining forms were left for future research. In the last two column of this Table is shown the % population of the different tautomers at 298.15 K and 273.15 K. At room temperature the largest population corresponds to tautomer N1 (48.1%). The second population is due to OHC tautomer (37.7%) and the third one is to OHT (14.3%). Tautomers N3 and N7 have very little population, less than 0.05%.

![Five tautomers described in acyclovir.](pharmaceuticals-07-00695-g002){#pharmaceuticals-07-00695-f002}

pharmaceuticals-07-00695-t001_Table 1

###### 

The optimum stable tautomers calculated in acyclovir molecule at the levels: B3LYP/6-311++G(3df,pd) (values in bold); MP2/6-31G(d,p) (values in key); B3LYP/6-31G(d,p) (values in normal); O3LYP/6-31G(d,p) (values in brackets); B3PW91/6-31G(d,p) (values in parenthesis); B3LYP/cc-pVDZ (values in quotation marks) and B972/6-31G(d,p) (values in italic type). Torsional angles in degrees, dipole moments in debyes, distance R in Å, energy increments in kcal·mol^−1^ and population (%) at 298.15 K (P~298.15~) and at 273.15 K (P~273.15~).

  Tautomers   R           β          Φ           φ~1~        φ~2~        φ~3~        φ~4~        φ~5~        μ           ΔE              ΔG       P~298.15~   P~273.15~
  ----------- ----------- ---------- ----------- ----------- ----------- ----------- ----------- ----------- ----------- --------------- -------- ----------- -----------
  **N1**      **3.963**   **72.5**   **54.3**    **−75.3**   **146.4**   **−88.5**   **69.8**    **−69.3**   **5.739**   **0** **^a^**                        
  {3.892}     {73.5}      {51.3}     {−71.9}     {150.3}     {−94.6}     {69.1}      {−75.4}     {6.207}     {0} ^b^                                          
  3.925       72.3        53.7       −74.1       144.7       −93.4       71.1        −73.3       5.375       0 ^c^       0 ^d^           48.1     49.2        
  \[3.956\]   \[72.7\]    \[53.9\]   \[−75.4\]   \[144.5\]   \[−94.0\]   \[71.5\]    \[−72.1\]   \[5.369\]   \[0\] ^e^   \[0.638\] ^f^                        
  (3.891)     (72.7)      (53.2)     (−75.1)     (145.2)     (−92.3)     (70.3)      (−74.1)     (5.492)     \(0\) ^g^   \(0\) ^h^                            
  "3.922"     "72.0"      "54.0"     "−73.9"     "143.2"     "−92.0"     "72.3"      "−74.4"     "5.34"      "0" ^i^     "0" ^j^                              
  *3.913*     *72.8*      *53.3*     −*75.0*     *145.3*     −*93.4*     *70.8*      − *73.6*    5.502       *0* ^k^     *0* ^l^                              
  **N3**      {3.672}     {77.0}     {53.5}      {−45.9}     {149.1}     {−92.5}     {60.2}      {−92.6}     {12.220}    {25.457}                             
  3.877       80.5        49.5       −48.4       155.0       −93.9       61.1        −88.        11.183      25.529      24.811          \<0.05   \<0.05      
  **N7**      {3.741}     {73.0}     {52.0}      {−76.4}     {140.5}     {−80.8}     {72.4}      {−92.7}     {9.841}     {19.302}                             
  3.745       72.8        53.3       −79.9       136.9       −78.5       71.8        −91.5       7.785       17.516      17.689          \<0.05   \<0.05      
  **OHC**     {3.826}     {73.5}     {51.7}      {−72.3}     {146.5}     {−89.2}     {70.4}      {−82.6}     {2.471}     {0.603}                              
  3.839       72.9        53.4       −75.9       141.9       −87.0       71.1        −81.5       2.100       0.145       0.284           37.7     37.7        
  **OHT**     {3.792}     {73.5}     {52.0}      {−72.4}     {145.0}     {−87.2}     {70.6}      {−86.1}     {3.437}     {1.131}                              
  3.806       72.9        53.6       −76.2       140.7       −85.0       71.0        −84.9       2.105       0.719       0.830           14.3     13.1        

^a^ Δ*E* = 0 = −811.214731 a.u. at B3LYP/6-311++G(3df,pd) level; ^b^ Δ*E* = 0 = −808.643998 a.u. at MP2/6-31G(d,p) level; ^c^ Δ*E* = 0 = −810.723396 a.u. at B3LYP/6-31G(d,p) level; ^d^ Δ*G* = 0 = −810.764701 a.u.; ^e^ Δ*E* = 0 = −810.449499 a.u. at O3LYP/6-31G(d,p) level; ^f^ Δ*G* = 0 = −810.490782 a.u.; ^g^ Δ*E* = 0 = −810.419555 a.u. at B3PW91/6-31G(d,p) level; ^h^ Δ*G* = 0 = −810.460766 a.u.; ^i^ Δ*E* = 0 = −810.760402 a.u. at B3LYP/cc-pVDZ level; ^j^ Δ*G* = 0 = −810.801662 a.u.; ^k^ Δ*E* = 0 = −810.444324 a.u. at B972/6-31G(d,p) level; ^l^ Δ*G* = 0 = −810.485454 a.u.

An analysis of the relative energies of these tautomers shows that they can be related to the dipole moment (μ) and to the torsional angle φ~1~, [Figure 3](#pharmaceuticals-07-00695-f003){ref-type="fig"}. Thus, the least stable tautomer in the isolated state (N7) has the highest μ, *i.e.*, it is the most stable in water solution. Other relations can be observed between Δ*E* and φ~1~. It is noted that tautomer N7 has the highest negative value of φ~1~ angle.

![Relationship/tendency observed between the relative electronic energy Δ*E* + ZPE correction of the different tautomers *vs*. (**a**) the dipole moment μ. and (**b**) the exocyclic torsional angle φ~1~.](pharmaceuticals-07-00695-g003){#pharmaceuticals-07-00695-f003}

3.1. Definition of the Conformational Angles
--------------------------------------------

The atomic description of tautomer N1 of ACV, as well as the most important exocyclic and endocyclic torsional angles, is defined in [Figure 1](#pharmaceuticals-07-00695-f001){ref-type="fig"}. The conformation can be characterized by the following five torsional angles: (i) the torsional angle, φ~1~(C4-N9-C1\'-O2\'), which determines the two orientations of the base relative to the opened chain, denoted in the present manuscript as conformers A and B; (ii) The exocyclic torsional angle φ~2~ (N9-C1\'-O2\'-C3\'); (iii) φ~3~ (C1\'-O2\'-C3\'-C4\') that determine the different folds of the chain; (iv) φ~4~(O2\'-C3\'-C4\'-O5\') describing the O5\'H orientation; and (v) the torsional angle φ~5~ (C3\'-C4\'-O5\'-H5\') that define the orientation of the hydroxyl hydrogen H5\'. This φ~5~ angle has some similarities with the β angle of the nucleosides \[[@B43-pharmaceuticals-07-00695]\].

Considering the structure of the chain, that likes the structure of the sugar in the nucleosides, and in accordance to previous works \[[@B45-pharmaceuticals-07-00695]\], other three structural parameters were defined to fix the chain position respect to the plane of the nucleobase: (vi) The vector R (N9···O5\') which determines the distance of the OH group relative to the base; (vii) The angle β (C4-N9···O5\') which defines the angle of the OH group relative to the base plane; and (viii) the angle Φ (C1\'-N9···O5\') which also determines the position of the OH group.

3.2. Conformers and Energetics
------------------------------

An extensive conformational study of tautomer N1 was carried out through a rotation of the exocyclic φ~1~, φ~2~, φ~3~, φ~4~and φ~5~ torsional angles. A detailed collection of the most important conformational parameters of these optimized forms is included in [Table 2](#pharmaceuticals-07-00695-t002){ref-type="table"}. The conformers were classified according to the two ranges of rotation of φ~1~: conformers A with the φ~1~values negative and conformers B with φ~1~ positive.

Two energy criteria were considered for each conformer: the electronic energy Δ*E* + ZPE correction, and the Gibbs energy Δ*G*. For the numbering of the conformers in each range of rotation of φ~1~ was followed the Δ*E* + ZPE criterion. Calculations at different levels, as well as single point calculations at the MP2/6-31G(d,p)//B3LYP/6-31G(d,p) level were carried out to confirm the stability of the main conformers, [Table 2](#pharmaceuticals-07-00695-t002){ref-type="table"} and [Table 3](#pharmaceuticals-07-00695-t003){ref-type="table"}. In general, the stability order remains, although several changes are observed. Thus, conformer B2 appears as the most stable one instead of A1 predicted by the DFT methods. The % population of the different conformers at 298.15 K (P~298.15~) and at 273.15 K (P~273.15~) was calculated. It indicates that only confomers A1 (41.5%), B1 (36.1%), B2 (9.6%) and A2 (8.7%) have importance. The population of the remaining conformers is lower than 1% and thus they are not of interest. The temperature effect is not significant.

By the same methodology, the relative energies of the different conformers have been determined in related nucleosides \[[@B34-pharmaceuticals-07-00695],[@B46-pharmaceuticals-07-00695],[@B47-pharmaceuticals-07-00695],[@B48-pharmaceuticals-07-00695]\]. The global minimum calculated in these molecules by MP2/6-31G(d,p) was in accordance to that found by B3LYP/6-31G(d,p). Thus, our results by B3LYP can be considered acceptable.

pharmaceuticals-07-00695-t002_Table 2

###### 

The 78 optimum stable conformers calculated in tautomer N1 of acyclovir molecule at the levels: B3LYP/6-311++G(3df,pd) (values in bold); MP2/6-31G(d) (values in keys); B3LYP/6-31G(d,p) (values in normal type); O3LYP/6-31G(d,p) (values in brackets); B3PW91/6-31G(d,p) (values in parenthesis); B3LYP/cc-pVDZ (values in quotation marks) and B972/6-31G(d,p) (values in italic type) level. Distance R in Å, torsional angles in degrees, dipole moments in debyes, and energy increments in kcal·mol^−1^.

  Conformers   R           β ^a^       Φ ^a^        φ~1~         φ~2~         φ~3~         φ~4~        φ~5~        μ           ΔE              ΔG
  ------------ ----------- ----------- ------------ ------------ ------------ ------------ ----------- ----------- ----------- --------------- -------
  A1           **3.963**   **72.5**    **54.3**     **−75.3**    **146.4**    **−88.5**    **69.8**    **−69.3**   **5.739**   **0** **^b^**   
  {2.859}      {73.8}      {50.9}      {−71.8}      {151.8}      {−96.3}      {68.8}       {−74.2}     {6.182}     {0.064}                     
  3.925        72.3        53.7        −74.1        144.7        −93.4        71.1         −73.3       5.375       0 ^c^       0 ^d^           
  \[3.956\]    \[72.7\]    \[53.9\]    \[−75.4\]    \[144.5\]    \[−94.0\]    \[71.5\]     \[−72.1\]   \[5.369\]   \[0\] ^e^   \[0.638\]       
  (3.891)      (72.7)      (53.2)      (−75.1)      (145.2)      (−92.3)      (70.3)       (−74.1)     (5.492)     \(0\) ^f^   \(0\) ^g^       
  "3.922"      "72.0"      "54.0"      "−73.9"      "143.2"      "−92.0"      "72.3"       "−74.4"     "5.343"     "0" ^h^     "0" ^i^         
  *3.913*      *72.8*      *53.3*      − *75.0*     *145.3*      − *93.4*     *70.8*       − *73.6*    *5.502*     *0* ^j^     *0* ^k^         
  A2           **3.774**   **76.8**    **52.5**     **−97.7**    **65.9**     **74.6**     **−67.0**   **−34.1**   **5.367**   **1.258**       
  {3.727}      {77.7}      {50.7}      {−96.9}      {66.0}       {76.2}       {−65.5}      {−42.7}     {5.776}     {0.095}                     
  2.892        77.3        51.5        −97.0        67.7         72.4         −65.1        −39.3       5.382       0.928       1.324           
  \[3.779\]    \[77.9\]    \[51.3\]    \[−98.8\]    \[68.1\]     \[72.8\]     \[−65.5\]    \[−38.3\]   \[5.361\]   \[1.189\]   \[2.009\]       
  (3.715)      (77.0)      (51.6\]     (−97.4)      (67.4)       (72.8)       (−65.4)      (−38.6)     (5.436)     (0.655)     (1.034)         
  "3.730"      "77.1"      "51.6"      "−96.6"      "67.6"       "72.4"       "−64.9"      "−38.4"     "5.385"     "1.000"     "1.370"         
  *3.736*      *77.4*      *51.5*      − *97.9*     *67.4*       *73.2*       − *65.5*     − *38.7*    *5.438*     *1.000*     *1.018*         
  A3           **5.155**   **118.5**   **37.5**     **−107.7**   **71.0**     **171.1**    **−63.7**   **57.6**    **5.762**   **1.202**       
  {5.004}      {111.4}     {37.6}      {−101.9}     {64.7}       {164.9}      {−61.1}      {53.9}      {5.586}     {2.240}                     
  5.104        118.6       36.4        −108.5       69.9         168.3        −61.1        53.4        5.594       2.303       1.014           
  \[5.149\]    \[121.2\]   \[36.1\]    \[−112.1\]   \[71.9\]     \[168.7\]    \[−63.0\]    \[55.9\]    \[5.653\]   \[0.585\]   \[0.073\]       
  (5.079)      (119.1)     (36.8)      (−110.2)     (69.3)       (168.7)      (−60.9)      (52.4)      (5.702)     (1.795)     (0.553)         
  "5.105"      "120.0"     "36.7"      "−109.9"     "71.0"       "169.9"      "−60.7"      "52.5"      "5.610"     "2.864"     "1.513"         
  *5.094*      *119.1*     *36.7*      − *110.0*    *69.6*       *168.6*      − *61.9*     *54.8*      *5.673*     *2.864*     *0.095*         
  A4           **4.592**   **116.2**   **64.7**     **−106.0**   **73.2**     **178.6**    **65.0**    **−56.8**   **7.630**   **1.726**       
  {4.487}      {113.4}     {64.9}      {−100.7}     {67.1}       {178.0}      {61.3}       {−52.8}     {8.026}     {2.887}                     
  4.517        117.5       65.1        −106.7       71.7         −179.5       62.2         −52.9       7.390       2.765       1.457           
  \[4.552\]    \[119.3     \[65.0\]    \[−109.9\]   \[73.7\]     \[−179.3\]   \[64.3\]     \[−55.3\]   \[7.309\]   \[1.030\]   \[0.432\]       
  (4.500)      (118.5)     (65.1)      (−107.9)     (71.0)       (−179.6)     (62.0)       (−52.8)     (7.480)     (2.309)     (1.009)         
  "4.500"      "117.5"     "65.1"      "−107"       "71.0"       "−179.6"     "62.0"       "−52.8"     "7.480"     "3.256"     "1.871"         
  *4.515*      *118.4*     *65.1*      −*108.2*     *71.4*       −*179.7*     *62.9*       −*54.0*     *7.467*     *3.256*     *0.503*         
  A5           5.119       123.3       36.2         −81.4        −71.2        −170.1       60.7        −53.6       5.166       2.952           1.976
  A6           4.839       130.3       50.2         −93.9        −178.3       174.3        −60.6       54.4        7.387       3.870           2.472
  A7           4.342       110.7       69.0         −100.5       73.3         −114.2       −57.0       53.3        4.342       4.088           2.821
  A8           5.314       99.1        61.8         −108.8       70.2         174.4        179.8       123.1       5.490       4.529           3.020
  A9           4.316       72.3        29.9         −100.9       86.9         94.8         −69.7       165.3       8.401       4.540           3.284
  A10          4.317       98.8        29.8         −100.4       87.1         62.4         118.4       −119.6      8.402       4.541           3.295
  A11          4.316       98.8        29.8         −100.5       87.1         94.7         −69.8       165.6       8.403       4.541           3.293
  A12          5.248       97.3        61.6         −107.1       71.8         176.2        −179.4      177.3       6.700       4.778           3.132
  A13          5.137       115.6       37.5         −109.6       69.9         168.6        −72.0       169.7       6.500       4.912           3.329
  A14          3.804       130.6       83.0         −137.1       68.2         −147.3       63.6        64.2        7.916       4.944           4.017
  A15          3.851       140.4       75.7         −114.8       −115.6       140.7        −61.6       63.4        7.669       5.082           3.917
  A16          4.561       120.1       66.8         −112.4       70.5         −178.3       63.9        60.5        7.527       5.103           3.411
  A17          4.400       99.7        34.4         −112.0       67.2         57.8         44.9        48.3        6.225       5.139           4.217
  A18          5.204       119.3       39.3         −110.7       69.8         173.8        −64.3       −63.3       7.512       5.216           3.730
  A19          3.411       68.6        64.3         −92.1        98.3         −114.1       64.4        39.1        7.760       5.354           4.890
  A20          4.387       136.6       10.3         −88.2        158.8        79.4         −71.0       172.6       8.042       5.378           3.969
  A21          3.562       167.7       60.8         −94.2        −126.1       83.2         −74.5       178.0       6.300       5.384           4.494
  A22          4.486       118.5       67.8         −112.8       70.8         −179.7       71.7        −171.9      8.081       5.432           3.764
  A23          5.209       88.5        51.3         −104.5       77.3         91.3         180.0       −69.9       6.218       5.476           3.817
  A24          4.381       115.3       11.5         −102.7       −162.7       −77.3        73.0        −170.7      8.685       5.514           4.179
  A25          4.948       80.5        59.5         −102.5       67.2         74.6         176.3       −68.2       6.425       5.588           4.277
  A26          4.655       80.0        78.1         −99.5        74.6         −104.0       −175.2      72.4        7.000       5.633           4.093
  A27          4.609       83.1        78.2         −102.2       71.5         −107.6       −174.8      179.6       5.473       5.662           4.371
  A28          5.146       128.0       36.4         −81.4        −70.5        −167.5       71.8        −170.7      6.229       5.675           4.396
  A29          4.653       84.8        51.8         −103.7       70.9         −109.1       −174.5      −74.1       6.731       5.845           4.325
  A30          5.235       90.1        49.7         −102.9       80.0         96.4         179.4       −173.8      7.848       5.850           4.085
  A31          4.400       99.7        34.4         −112.0       67.2         57.8         44.9        48.3        6.225       5.890           4.508
  A32          5.220       123.3       38.2         −81.4        −70.2        −172.6       64.6        64.8        4.345       5.909           4.708
  A33          4.415       114.1       12.6         −104.1       −163.1       −74.6        69.3        69.4        7.384       5.917           4.782
  A34          5.955       104.4       31.3         −95.4        179.0        −178.1       179.2       72.9        6.080       6.174           4.503
  A35          5.898       124.0       30.3         −96.6        179.3        179.3        179.9       179.6       6.676       6.195           4.544
  A36          5.956       124.3       31.3         −96.4        179.5        178.1        −179.0      −72.9       7.716       6.254           4.762
  A37          4.565       102.4       34.8         −112.6       66.4         60.5         56.3        −178.8      7.684       6.290           5.085
  A38          4.273       110.2       72.9         −105.8       71.1         −103.2       −66.6       167.8       6.458       6.432           4.855
  A39          4.970       138.6       46.2         −100.0       −179.8       172.1        −72.6       166.4       8.071       6.610           4.755
  A40          5.011       104.7       46.2         −97.2        −179.7       −176.1       72.9        −166.1      7.023       6.779           5.097
  A41          5.030       104.4       48.4         −95.2        179.6        −177.9       64.3        61.5        8.220       7.100           5.519
  A42          5.722       115.4       19.7         −99.3        −176.9       −84.1        −179.2      70.4        6.405       7.372           5.289
  A43          5.350       87.6        45.5         −90.3        138.5        −88.9        −177.6      −70.3       7.007       7.483           7.510
  A44          5.386       92.4        40.2         −91.6        146.1        −91.1        178.5       173.8       7.133       7.627           5.567
  A45          5.699       118.8       18.3         −101.1       −173.8       −84.4        −178.6      176.1       7.994       7.665           5.672
  A46          5.765       120.0       17.5         −101.1       −170.2       −80.2        −173.9      −69.9       6.680       7.684           5.636
  A47          4.832       106.9       33.0         −107.0       −164.9       −72.0        −62.7       178.1       8.554       8.451           6.636
  B1           **3.928**   **73.4**    **53.4**     **75.1**     **−146.7**   **95.5**     **−68.8**   **72.8**    **5.812**   **0.072**       
  {3.885}      {74.5}      {50.3}      {70.1}       {−151.5}     {94.2}       {−68.1}      {76.8}      {6.204}     {0.056}                     
  3.880        73.4        52.8        73.5         −145.4       90.9         −69.3        76.7        6.746       0.083       0.151           
  \[3.927\]    \[73.6\]    \[53.1\]    \[74.4\]     \[−145.4\]   \[92.6\]     \[−69.8\]    \[74.6\]    \[5.485\]   \[0.124\]   \[0.822\]       
  (3.855)      (73.5)      (55.6)      (74.2)       (−145.7)     (90.5)       (−68.9)      (76.7)      (5.595)     (0.061)     (0.108)         
  "3.870"      "73.3"      "51.1"      "73.1"       "−144.2"     "89.6"       "−70.0"      "77.7"      "5.374"     "0.099"     "0.195"         
  *3.882*      *73.7*      *52.7*      *74.0*       −*145.8*     *91.5*       −*69.3*      *76.0*      *5.601*     *0.099*     *0.090*         
  B2           **3.770**   **77.2**    **52.0**     **97.0**     **−66.7**    **−74.1**    **66.6**    **36.1**    **5.348**   **1.216**       
  {3.726}      {17.9}      {50.4}      {95.6}       {−66.8}      {−75.8}      {65.5}       {44.0}      {5.664}     {0}^l^                      
  2.905        77.6        51.2        96.4         −68.5        −72.0        65.1         40.6        5.340       0.87        1.251           
  \[3.784\]    \[78.0\]    \[50.8\]    \[98.5\]     \[−68.9\]    \[−72.6\]    \[65.4\]     \[40.4\]    \[5.321\]   \[1.118\]   \[1.900\]       
  (3.713)      (77.3)      (51.2)      (96.8)       (−68.2)      (−72.4)      (65.4)       (39.9)      (5.404)     (0.612)     (0.975)         
  "3.727"      "77.5"      "51.2"      "96.2"       "−68.4"      "−72.9"      "64.0"       "39.8"      "5.250"     "0.968"     "1.316"         
  *3.736*      *77.8*      *51.1*      *97.3*       −*68.2*      −*72.8*      *65.4*       *40.3*      *5.398*     *0.968*     *0.941*         
  B3           **5.157**   **117.3**   **37.3**     **106.1**    **−71.7**    **−171.1**   **63.5**    **−57.6**   **5.951**   **1.157**       
  {5.007}      {110.9}     {37.4}      {100.4}      {−65.2}      {−165.1}     {60.9}       {−53.8}     {5.998}     {2.179}                     
  5.104        117.9       36.2        107.1        −70.3        −168.1       60.9         −53.3       5.839       2.257       0.903           
  \[5.149\]    \[120.9\]   \[35.9\]    \[111.5\]    \[−72.1\]    \[−168.6\]   \[62.9\]     \[−55.9\]   \[5.872\]   \[0.542\]   \[0\]^m^        
  (5.080)      (118.1)     (36.5)      (108.2)      (−69.7)      (−168.2)     (60.8)       (−53.3)     (5.921)     (1.748)     (0.412)         
  "5.106"      "119.5"     "36.5"      "108.6"      "−71.3"      "−169.7"     "60.6"       "−52.4"     "5.814"     "2.819"     "1.394"         
  *5.094*      *118.6*     *36.6*      *108.9*      −*69.9*      −*168.4*     *61.7*       −*54.7*     *5.907*     *2.819*     *0.001*         
  B4           **4.529**   **95.5**    **65.4**     **78.3**     **70.8**     **−178.7**   **63.6**    **−54.4**   **6.470**   **2.031**       
  {3.673}      {66.1}      {78.5}      {56.6}       {63.8}       {−147.2}     {63.0}       {−52.4}     {6.649}     {1.707}                     
  3.817        68.7        79.7        56.7         64.6         −149.1       63.8         −50.2       5.870       2.722       2.366           
  \[4.300\]    \[85.9\]    \[70.0\]    \[69.9\]     \[70.9\]     \[−168.2\]   \[63.2\]     \[−52.1\]   \[6.144\]   \[1.331\]   \[0.867\]       
  (3.814)      (68.9)      (79.4)      (56.4)       (64.5)       (−150.0)     (63.4)       (−48.6)     (5.913)     (2.523)     (2.080)         
  "3.839"      "68.8"      "79.2"      "55.9"       "65.4"       "−150.2"     "63.6"       "−48.6"     "5.680"     "3.179"     "2.791"         
  *3.858*      *70.3*      *78.6*      *58.0*       *64.6*       −*151.4*     *63.4*       −*49.6*     *5.949*     *3.179*     *1.557*         
  B5           **4.598**   **115.9**   **64.6**     **105.4**    **−72.8**    **−178.2**   **−64.9**   **56.7**    **7.911**   **1.693**       
  {4.507}      {112.9}     {64.3}      {99.6}       {−66.5}      {−177.0}     {−61.1}      {52.8}      {8.520}     {2.832}                     
  4.526        117.5       64.8        106.4        −71.4        180.0        −62.0        52.8        7.735       2.757       1.463           
  \[4.559\]    \[119.2\]   \[64.9\]    \[109.6\]    \[−73.3\]    \[179.7\]    \[−64.2\]    \[55.2\]    \[7.629\]   \[1.012\]   \[0.420\]       
  (4.510)      (118.4)     (64.8)      (107.6)      (−70.7)      −179.9       (−61.8)      (52.7)      (7.826)     (2.289)     (0.978)         
  "4.524"      "117.6"     "64.7"      "106.6"      "−72.3"      "−179.9"     "−61.7"      "52.1"      "7.517"     "3.262"     "1.920"         
  *4.524*      *118.3*     *64.8*      *107.6*      −*71.1*      −*179.8*     −*62.7*      *53.8*      *7.793*     *3.262*     *0.470*         
  B6           5.119       123.1       36.3         81.0         70.9         170.1        −60.7       54.1        5.460       2.993           2.035
  B7           4.991       113.3       29.3         107.2        −74.7        −87.7        −56.9       46.5        6.027       3.636           2.427
  B8           3.582       165.9       56.3         82.7         65.4         73.0         −75.2       178.4       6.463       4.240           3.708
  B9           3.793       70.4        79.1         57.2         68.0         −93.9        −49.8       60.8        5.069       4.263           3.900
  B10          4.325       99.2        29.1         98.3         −88.0        −94.7        69.5        −166.2      8.268       4.496           3.334
  B11          5.318       99.2        61.7         108.3        −70.8        −175.3       179.6       71.1        5.640       4.508           3.006
  B12          5.002       132.0       29.1         77.5         74.7         88.4         57.0        −46.2       5.222       4.791           3.824
  B13          5.138       115.0       37.3         108.2        −70.2        −168.4       71.8        −170.5      6.133       4.845           3.212
  B14          5.246       98.4        61.7         108.6        −71.5        −176.6       179.2       177.1       6.553       4.852           3.244
  B15          5.312       99.2        62.1         108.6        −70.7        −175.8       −178.5      −70.6       7.964       4.893           3.413
  B16          4.407       99.6        33.7         110.2        −68.1        −57.9        −44.6       −48.7       5.939       5.042           4.065
  B17          5.205       118.2       39.0         109.3        −69.6        −172.9       64.6        63.9        7.429       5.101           3.551
  B18          3.562       167.3       60.9         93.8         125.8        −83.0        74.6        −178.0      6.069       5.456           4.582
  B19          5.277       89.9        49.5         103.3        −79.4        −94.8        −179.7      69.2        6.054       5.577           3.960
  B20          4.876       78.3        61.1         101.0        −65.9        −75.2        179.3       −69.0       6.102       5.694           4.494
  B21          5.253       91.0        49.4         103.8        −80.2        −97.6        −178.6      174.8       8.034       5.950           3.922
  B22          4.534       101.8       35.0         112.6        −66.2        −59.3        −55.7       179.6       7.559       6.169           5.032
  B23          3.146       83.0        95.1         73.1         67.3         −116.9       63.5        64.3        5.334       6.305           6.199
  B24          4.610       77.9        77.5         79.0         72.8         −102.2       −173.9      −175.2      5.317       6.617           5.315
  B25          4.365       150.0       33.5         76.4         67.0         59.5         40.5        41.6        5.882       6.677           5.427
  B26          4.618       108.0       52.5         77.2         68.5         −105.1       −173.1      −79.3       5.308       6.689           5.500
  B27          5.184       143.6       51.8         78.9         76.5         89.5         −178.9      −69.4       6.563       6.718           5.374
  B28          4.635       114.4       78.3         79.8         73.8         −101.1       −174.8      72.3        7.031       6.831           5.483
  B29          5.194       141.1       52.7         77.5         74.5         87.3         175.3       68.0        5.203       6.997           5.596
  B30          5.129       142.9       52.3         79.1         76.5         90.0         −179.5      −175.2      7.031       7.015           5.609
  B31          4.964       136.4       32.2         77.2         71.0         78.8         64.1        −178.9      5.033       7.508           6.051

^a^ Notation used from ref. \[[@B49-pharmaceuticals-07-00695]\]; ^b^ Δ*E* = 0 = −811.214731 a.u. at B3LYP/6-311++G(3df,pd) level; ^c^ Δ*E* = 0 = −810.723396 a.u. at B3LYP/6-31G(d,p) level; ^d^ Δ*G* = 0 = −810.764701 a.u.;^e^ Δ*E* = 0 = −810.449499 a.u. at O3LYP/6-31G(d,p) level; ^f^ Δ*E* = 0 = −810.419555 a.u. at B3LYP/cc-pVDZ level; ^g^ Δ*G* = 0 = −810.460766 a.u.; ^h^ Δ*E* = 0 = −810.760402 a.u. at B3PW91/6-31G(d,p) level; ^i^ Δ*G* = 0 = −810.801662 a.u.; ^j^ Δ*E* = 0 = −810.444324 a.u. at B972/6-31G(d,p) level; ^k^ Δ*G* = 0 = −810.485454 a.u.; ^l^ Δ*E* = 0 = −808.643998 a.u. at MP2/6-31G(d) level; ^m^ Δ*G* = 0 = −810.491798 a.u.
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###### 

Single point calculations at the MP2/6-31G(d,p)//B3LYP/6-31G(d,p) level.

  Conformer   Δ*E*/kcal·mol^−1^
  ----------- -------------------
  A1          0.143
  A2          0.082
  A3          2.553
  A4          3.112
  B1          0.122
  B2          0
  B3          2.491
  B4          1.962
  B5          3.071

The conformers differ in general very little in energy. Thus, in our calculations 78 optimized conformers were found within the electronic energy range Δ*E* = 0--8.5 kcal/mol, and Gibbs energy range Δ*G* = 0--6.6 kcal/mol with respect to the global minimum. This range of values of Δ*G* is smaller than that calculated in dG, in dT \[[@B50-pharmaceuticals-07-00695]\], 0--7 kcal/mol and in dU \[[@B31-pharmaceuticals-07-00695]\], 0--9 kcal/mol.

Only four conformers are found within the electronic energy range Δ*E* = 0--1.0 kcal/mol (by criterium of Δ*E* + ZPE), [Table 2](#pharmaceuticals-07-00695-t002){ref-type="table"}, with φ~1~ −72°/−97° as *g*^−^ and 70°/96° as *g*^+^ by MP2. Among these conformers, B1 has the highest dipole moment 6.20 D although very close to that in A1, 6.18 D. These conformers are slightly favored in a polarizable environment with water.

Another seven conformers appear within the electronic energy range Δ*E* = 1.0--3.0 kcal/mol, three values were *anti* (φ~1~ *ca.* −100°) and four *syn* (φ~1~ *ca.* 90°). The *anti* structures are the expected forms in the natural nucleosides that form the nucleotides and polynucleotides in biological systems \[[@B33-pharmaceuticals-07-00695],[@B35-pharmaceuticals-07-00695],[@B46-pharmaceuticals-07-00695],[@B47-pharmaceuticals-07-00695],[@B48-pharmaceuticals-07-00695]\]. The ratio *anti/syn* in conformers A is 0.8 in the low-energy group (\<3 kcal/mol) but it increases up to 1.7 in the 3.0--8.5 kcal/mol range.

The global minimum by DFT methods corresponds to the conformer denoted as A1 ([Figure 4](#pharmaceuticals-07-00695-f004){ref-type="fig"}) and it appears stabilized by an intramolecular H-bond. The optimised bond lengths and natural NBO atomic charges on this conformer are collected in [Figure 5](#pharmaceuticals-07-00695-f005){ref-type="fig"}. This global minimum by criterium of Δ*E* + ZPE agree well to that obtained by criterion of Δ*G,* but differs of that obtained by MP2/6-31G(d) and MP2/6-31G(d,p)//B3LYP/6-31G(d,p), [Table 3](#pharmaceuticals-07-00695-t003){ref-type="table"} and [Figure S3](#pharmaceuticals-07-00695-s001){ref-type="supplementary-material"}. It is because of the small difference in energy between both forms A1 and B2**.** This global minimum in the *syn* form by MP2 is in accordance to that obtained in other nucleosides \[[@B33-pharmaceuticals-07-00695],[@B34-pharmaceuticals-07-00695],[@B35-pharmaceuticals-07-00695]\] but differs of the *anti* form expected for the natural nucleosides and nucleotides in biological systems \[[@B43-pharmaceuticals-07-00695]\]. The second most stable conformer is B1 with values of φ~1~ = 70°, φ~2~ = −152° and φ~3~ = 94° by MP2.

[Figure 4](#pharmaceuticals-07-00695-f004){ref-type="fig"} shows the six best optimum conformers selected in the two ranges of φ~1~: three are **A** (A1--A3), and three are **B** (B1--B3). The values of the intramolecular H-bonds and the most important structural angles of each conformer are also included. [Figure 6](#pharmaceuticals-07-00695-f006){ref-type="fig"}, [Figure 7](#pharmaceuticals-07-00695-f007){ref-type="fig"}, [Figure 8](#pharmaceuticals-07-00695-f008){ref-type="fig"} and [Figure 9](#pharmaceuticals-07-00695-f009){ref-type="fig"} show the distribution of the 78 optimised conformers according to their energies, exocyclic torsional angles φ~1~--φ~5~, the angles β, Φ, and the vector R. The best significant conformers are pointed in these figures.

![Geometry of the six most optimum conformers selected for each rotation angle φ~1~ determined in A1 conformer of N1 tautomer of acyclovir at B3LYP/6-31G(d,p) level. The values of the strongest intramolecular H-bonds are also included.](pharmaceuticals-07-00695-g004){#pharmaceuticals-07-00695-f004}

![Natural atomic charges and optimum bond lengths in conformer B2 of tautomer N1 of acyclovir at B3LYP/6-31G(d,p) and MP2/6-31G(d,p) levels, in fuchsia and green colours, respectively.](pharmaceuticals-07-00695-g005){#pharmaceuticals-07-00695-f005}

![Distribution of the 78 optimum stable calculated conformers at the B3LYP/6-31G(d,p) level in tautomer N1 of acyclovir according to their exocyclic torsional angle φ~1~ and their: (**a**) relative electronic energy Δ*E* + ZPE correction; (**b**) relative Gibbs energy Δ*G*; and (**c**) the distance R. The most stable conformers of each type are pointed.](pharmaceuticals-07-00695-g006){#pharmaceuticals-07-00695-f006}

![Distribution of the 78 optimum stable calculated conformers in tautomer N1 of acyclovir, according to the values of the exocyclic torsional angles: φ~2~. φ~3~. φ~4~ and φ~5~ versus the angle φ~1~.](pharmaceuticals-07-00695-g007){#pharmaceuticals-07-00695-f007}

![Distribution of the 78 optimum stable calculated conformers in tautomer N1 of acyclovir according to the values of the angles Φ and β, and the dipole moment μ versus the angle φ~1~.](pharmaceuticals-07-00695-g008){#pharmaceuticals-07-00695-f008}

![3D plots with the relative energies of the 78 optimum stable conformers according to the values of the exocyclic torsional angles: φ~1~. φ~2~. φ~3~ and φ~4~ versus relative electronic energy Δ*E* + ZPE.](pharmaceuticals-07-00695-g009){#pharmaceuticals-07-00695-f009}

3.3. Conformational Angle Analysis
----------------------------------

An overall examination of the five exocyclic torsional angles and two bond angles, defining the conformational space in tautomer N1 of ACV, leads to conclude the following, [Figure 7](#pharmaceuticals-07-00695-f007){ref-type="fig"}, [Figure 8](#pharmaceuticals-07-00695-f008){ref-type="fig"} and [Figure 9](#pharmaceuticals-07-00695-f009){ref-type="fig"}: (i)The dihedral angle φ~1~ presents a bimodal distribution: (−137° ≤ −74°) 47 conformers **A** (*anti*) and (57° ≤ 113°) 31 conformers B (*syn*)**.** *Anti* forms prevail in number over *syn* ones and cover a slight wider range of φ~1~ values. This *anti* orientation has been found in the crystal of several nucleosides \[[@B51-pharmaceuticals-07-00695],[@B52-pharmaceuticals-07-00695],[@B53-pharmaceuticals-07-00695]\], and it is the form for biological activity \[[@B54-pharmaceuticals-07-00695]\]. Although, in many nucleoside analogues *syn* and *anti* forms have similar energy, however, the global minimum corresponds in general to the *syn* form, as in AZT \[[@B35-pharmaceuticals-07-00695]\]. In purine nucleosides there is relatively little restraint to rotation about the N9-C1\' bond \[[@B55-pharmaceuticals-07-00695]\]. In ACV the high population of the *anti* forms and the wider range of φ~1~ values are factors that facilitate its antiviral activity. The sugar ring of the natural nucleoside dG can be mimics by the similar exocyclic angles of ACV(ii)The torsional φ~2~ angle has a clear bimodal distribution: 65° ≤ φ~2~ ≤ 180° (49 conformers, 34 are A and 15 are B) and --180° ≤ φ~2~≤ −66° (29 conformers, 13 are A and 16 are B), [Figure 7](#pharmaceuticals-07-00695-f007){ref-type="fig"}(iii)The φ~3~ angle also has a bimodal conformation: 58° ≤ φ~3~≤ 180° (32 conformers, 22 are A and 10 are B) and −180° ≤ φ~3~≤ −58° (46 conformers, 25 are A and 21 are B)(iv)The φ~4~ angle has a trimodal distribution: −173° ≤ φ~4~≤ 175° (28 conformers, 16 are A and 12 are B), 41° ≤ φ~4~≤ 118° (28 conformers, 17 are A and 11 are B), and −75° ≤ φ~4~≤ −45° (22 conformers, 14 are A and 8 are B)(v)The torsional φ~5~ angle also has a trimodal distribution: −166° ≤ φ~5~≤ 165° (29 conformers, 19 A and 10 B), 39° ≤ φ~5~≤ 123° range (29 conformers, 16 A and 13 B), and −120° ≤ φ~5~≤ −46° (20 conformers, 12 A and 8 B)(vi)In the bond angle β has been observed a regular distribution in the 69° ≤ β ≤ 168° range, [Figure 8](#pharmaceuticals-07-00695-f008){ref-type="fig"}. This large range indicates the high flexibility of the chain with multiple O5\'H orientations. The most stable conformers with Δ*E* \< 1 kcal·mol^−1^ have the β angle with values between 72° and 78°, while the conformers with higher Δ*E* have some values larger than 140°.(vii)The bond Φ angle also shows a regular distribution in the 10° ≤ Φ ≤ 83° range for conformers A, and 29° ≤ Φ ≤ 95° for conformers B. The value of this angle appears between 51° and 54° for the four best conformers with Δ*E* \< 1 kcal/mol^−1^. In general, the most stable conformers do not have large values of Φ, neither low values.

Finally, the R vector has a large range of values, between 2.905Å and 5.956 Å, and it determines the distance of the OH end of the chain from the base plane.

3.4. Guanine Moiety
-------------------

In the analysis of the six most stable conformers, the base heterocycle has a very small non-planarity, in general with torsional angles lower than 1°, with the exception of those involving N3 and N9 atoms with a value higher than 2°. It is due to the strong intramolecular H5\'··N3 hydrogen bond which produces a ring deformation around N3. Thus, among the dihedral angles describing the base heterocycle nonplanarity, we have defined: ν~0~ (N1-C2=N3-C4), ν~1~ (C2=N3-C4=C5), ν~2~ (N3-C4=C5-C6), ν~3~ (N7=C8-N9-C4) and ν~4~ (C6-N1-C2=N3).

An analysis of the six most stable conformers ([Figure 4](#pharmaceuticals-07-00695-f004){ref-type="fig"}) shows that the highest base heterocycle nonplanarity corresponds to conformer A2 with the torsional angles ν~1~ (2.8°), ν~2~ (−2.3°) and ν~0~ (−1.3°). The other conformers show deviations higher than 1° in the following torsional angles: Conformer A1 in ν~2~ (−1.2°) and ν~3~ (−1.1°), conformer A3 in ν~1~ (1.5°) and ν~2~(−1.3°), conformer B1 in ν~0~ (1.3°) and ν~1~ (1.1°), and conformer B2 in ν~4~ (1.2°).

Comparing the bond lengths of ACV (conformer A1) with those of dG, it is observed that ACV has several bonds of the guanine moiety larger than the corresponding bonds in dG, while in the remaining bonds are smaller. The largest difference appears in C4-N3.

3.5. The Side Chain
-------------------

The most important characteristic of the structure of ACV is the conformation of the side chain that is attached to N9, which is characterized by the exocyclic torsional angles φ~1~ to φ~5~, by the bond angles β and Φ that determine the position of the chain from the base, and by the distance R. The bonds along this chain can be in *trans* respect to each other and thus it gives an extended zig-zag structure or, by contrast, one or several alternate bonds can be in *gauche* in such a way that it resembles at least partially a portion of the furanose moiety of dG \[[@B49-pharmaceuticals-07-00695],[@B56-pharmaceuticals-07-00695]\]. In this last case, it is capable of adopting conformations resembling a portion of the pentose ring, a factor which undoubtedly plays an important role in their biological activities \[[@B57-pharmaceuticals-07-00695]\]. Thus, three types of structures appear: two that have the side chain partially folded (conformers A and B), and one structure which has all bonds in *trans* orientation and leading to an almost planar zig-zag arrangement \[[@B49-pharmaceuticals-07-00695]\].

3.6. Intramolecular H-Bonds
---------------------------

Several authors have studied the intramolecular H-bonds in related nucleosides, in special using AIM method \[[@B58-pharmaceuticals-07-00695],[@B59-pharmaceuticals-07-00695]\]. However, the absence of the furanose ring in ACV reduces largely the number of possible H-bonds. Therefore, only two intramolecular H-bonds may be observed in the main conformers of ACV: (i) The hydroxyl hydrogen H5\'(O5\') and the guanine's position 3 nitrogen atom, H5\'···N3, and (ii) The hydroxyl hydrogen H5\'(O5\') and the guanine's position 2 oxygen atom, H5\'···O2\'.

[Figure 4](#pharmaceuticals-07-00695-f004){ref-type="fig"} shows these types of H-bonds in the six most stable conformers. H-bond (i) appears in conformers A1, B1, B2 and A2; while (ii) is observed in conformers B3 and A3 with values of 2.346 Å and 2.350 Å, respectively. H-bond (i) is stronger than (ii), and it gives a great stability to the structure. Thus, the conformers with the H-bond (i) are the most stable, Δ*E* \< 1 kcal·mol^−1^, while the conformers with the H-bond (ii) have higher energy, Δ*E* \> 2 kcal·mol^−1^.

3.7. Natural NBO Atomic Charges
-------------------------------

The calculated values in conformer A1 appear collected in [Figure 5](#pharmaceuticals-07-00695-f005){ref-type="fig"}. The largest negative charge corresponds to N2 and O5\' atoms, −0.90 and −0.84 *e*, respectively by MP2 (where *e* is the charge of an electron). The next atom with large negative charge is N1 (*ca.* −0.7 *e*). The value of this charge is slightly higher than in dG, −0.69 *e*. The main effect of the NH~2~ group is a remarkable increment in the positive charge on C2, 0.81 *e*, because of the high negative charge on the amino nitrogen, −0.90 *e*. Consequently, a noticeable increase of the negative charge on N3 is observed, −0.73 *e* (−0.70 *e* in dG). The electron-rich sites of the guanine moiety are involved in H-bonds, with N3 and O2\' acting as single acceptors.

In the nitrogen N9 the negative charge (−0.52 *e*) is lower than on N1, N3 and N7, but slightly higher than in dG. It is because in ACV the bonding to the chain increases the negative charge on N9. The value of the charge on N7 is important because in the neutral form of anti-tumour platinum drugs, the platinum atom has a strong preference for nitrogen N7 rather than for oxygen atoms of the base for its coordination \[[@B51-pharmaceuticals-07-00695]\]. Also, the N7 position in DNA is the most open to attack. N1 position is also important because when deprotonation of the weakly acid ACV occurs, the metal binding site changes to N1, which is the formally deprotonated site \[[@B60-pharmaceuticals-07-00695]\]. Raman spectra of related nucleosides in H~2~O indicate that the site of deprotonation in basic solutions is N1, while the site of protonation in acidic solutions is N3 and N7, the same sites that in its phosphorylated form. These results are useful for identification and characterization of its structure in natural occurring biopolymers \[[@B61-pharmaceuticals-07-00695]\].

The negative charge on the oxygen atoms is high, −0.65 *e* on O2\' and −0.69 *e* on O6. The values in O2\' and O5\' are slightly higher than in dG, by B3LYP −0.603 *e* and −0.761 *e*, respectively. By contrast, in O6 the negative charge is lower than in dG, −0.592 *e*.

C6 is the atom with the highest positive charge, 0.829 *e* by MP2, in concordance to the high negative charge on O6, *i.e.*, it is the most reactive. With a slightly lower value appears C2 (0.812 *e*), and with much lower values H5\'(O5^\'^), H1(N1), H2(N2) and H2\'(N2). The remaining hydrogen atoms have much less positive charge and they are less reactive.

3.8. Solid State Simulation
---------------------------

The structure of ACV (CSD code CEHTAK) in the solid state was determined by X-ray diffraction \[[@B53-pharmaceuticals-07-00695],[@B60-pharmaceuticals-07-00695],[@B61-pharmaceuticals-07-00695],[@B62-pharmaceuticals-07-00695],[@B63-pharmaceuticals-07-00695]\]. Birnbaum *et al*. \[[@B49-pharmaceuticals-07-00695],[@B62-pharmaceuticals-07-00695]\] obtained the crystals that belong to monoclinic space with three independent molecules (A, B and C), together with two water molecules \[[@B49-pharmaceuticals-07-00695]\]. Molecules A and B have similar conformation while that of molecule C is different, [Table 4](#pharmaceuticals-07-00695-t004){ref-type="table"}. In molecules A and B the angle φ~1~and φ~2~ are in the preferred *g*^−^ form, but in molecule C φ~2~ is in *trans*. It means that molecules A and B showed a partially folded conformation of the side chain, while molecule C appears extended \[[@B62-pharmaceuticals-07-00695]\]. Molecules A and B correspond to conformer A5 in the isolated state, while molecule C is represented by conformer A34. Molecules A and B are *ca.* 3 kcal·mol^−1^ more stable than molecule C. The difference in energy between molecule A and B is small and it is due to the flexibility of the side chains.
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A comparison of the most important structural parameters in the dimer and tetramer forms calculated at the B3LYP/6-31G(d,p) level in acyclovir molecule with those in the crystal. The torsional angles are in degrees and R in Å.

  Solid form                                      R       β       Φ       φ~1~    φ~2~     φ~3~     φ~4~     φ~5~
  ----------------------------------------------- ------- ------- ------- ------- -------- -------- -------- --------
  **Dimer**                                                                                                  
  Molecule A                                      5.150   127.9   −82.1   −82.1   −70.4    −168.4   71.9     −168.8
  Molecule B                                      5.148   127.9   −88.8   −88.8   −70.3    −168.1   71.8     −168.9
  **Tetramer**                                                                                               
  Molecule A                                      5.148   128.6   −82.3   −82.3   −70.4    −167.3   72.5     −167.4
  Molecule B                                      5.212   117.2   −80.1   −80.1   −76.3    176.8    64.2     −90.8
  Molecule C                                      5.110   122.0   158.6   158.6   −71.7    −50.5    60.1     −53.8
  Molecule D                                      4.313   150.6   −95.3   −95.3   −93.1    −100.2   70.6     −160.4
  **X-Ray** \[[@B62-pharmaceuticals-07-00695]\]                                                              
  Molecule A0                                                             −76.5   −76.9    173.2    60.6     
  Molecule B                                                              −74.4   −66.3    −176.2   73.5     
  Molecule C                                                              −90.5   −173.3   −171.9   −174.4   

We have simulated this arrangement through a dimer and tetramer forms, [Figure 10](#pharmaceuticals-07-00695-f010){ref-type="fig"}. The calculated value of the inter- and intramolecular H-bonds distances and the total energy is included in the Figure. The calculated bond lengths, bond angles and torsional angles are collected in [Tables S1 and S2](#pharmaceuticals-07-00695-s001){ref-type="supplementary-material"}. The simulated structure is tightly bonded but not so tight as it the reported in the crystal. There are four donor sites: H1(N1), H2(N2), H2\'(N2) and H5\', and five possible acceptors: O6, N3, N7, O2\' and O5\'.

![The optimized dimer and tetramer forms in conformer A1 of acyclovir at the B3LYP/6-31G(d,p) level. The H-bonds observed are in Å and the *E* (RB+HF-LYP) in a. u.](pharmaceuticals-07-00695-g010){#pharmaceuticals-07-00695-f010}

The dimer, and tetramer forms were built with the most stable conformer A1. In the dimer there are two intermolecular H-bonds between the two molecules: N1{in molecule A} and O6{in molecule B} 1.733 Å, and O6{in A} and N1{in B} 1.732 Å. The tetramer shows seven H-bonds: (i) two between molecule A and B: H~(N1)~{in molecule A} and O6{in molecule B} 1.709 Å, and O6{in molecule A} and H~(N1)~{in molecule B} 1.847 Å; (ii) There is only a H-bond between molecule B and C: H~(O5´)~{in B} and N3{in C}, 1.945 Å; (iii) There are two H-bonds between molecule C and D: H~(N1)~{in molecule C} and O6{in molecule D}, 1.741 Å, and O6{in C} and H~(N1)~{in D}, 1.792 Å. (iv) At list there are two H-bonds between molecule D and B: N7{in molecule D} and H~(N2\')~{in B}, 1.972 Å.

Comparing the calculated bond lengths and angles of molecule A in the dimer with the X-ray data \[[@B62-pharmaceuticals-07-00695]\], [Tables S2 and S3](#pharmaceuticals-07-00695-s001){ref-type="supplementary-material"}, it is observed the good agreement in the values of our simulated structure. The greater differences appear in C4=C5 (0.025 Å), C2-N2 (0.023 Å), C3\'-C4\' and N1-C6 (0.016 Å), and the difference is almost null in C6=O, C5-N7, N7=C8 and C4-N9. A slight larger error is obtained when the comparison theory-experiment is carried out with the molecule B of the dimer. This error is slight reduced when the comparison is carried out with the simulated molecule A of the tetramer. In the angles the difference is almost null, with similar values of all the angles. Only several angles in the side chain show some noticeable differences, *i.e.*, C3\'-C4\'-O5\', 4.7°.

Other four anhydrous forms of ACV and a new hydrate have been characterized by X-ray diffraction, with significant differences in the intermolecular H-bonding networks among the ACV forms \[[@B63-pharmaceuticals-07-00695],[@B64-pharmaceuticals-07-00695],[@B65-pharmaceuticals-07-00695]\]. A study of the solution forms of ACV shows that ACV can exist as polymorphic and pseudopolymorphic solvates \[[@B66-pharmaceuticals-07-00695]\]. We have simulated other dimer, trimer and pentamer forms with different conformers and collected in [Figure S4](#pharmaceuticals-07-00695-s001){ref-type="supplementary-material"}.

4. Conclusions
==============

In the present work we have shown a comprehensive compendium of the possible conformers in tautomer N1 of ACV. The geometries and values of the properties presented here appear to the most accurate to date. The most important findings of the present work are the following: (1)Five tautomers of ACV were identified and fully optimized. At room temperature only tautomer N1 (48.1%), OHC (37.7%) and OHT (14.3%) have a noticeable population. It is very small in tautomers N3 and N7, less than 0.05%.(2)The relative energies of the five tautomers appear related to the dipole moment and to the torsional angle φ~1~. The least stable tautomer N3 in the isolated state has the highest μ and thus, it is the most favoured in a polarisable environment with water.(3)In the isolated state the most stable tautomer is N1 by both B3LYP and MP2 methods. In this tautomer, and through a rotation of φ~1~, φ~2~, φ~3~, φ~4~ and φ~5~ exocyclic torsional angles, 78 optimized stable conformers were identified, two *syn* and two *anti* failing into the 0--1 kcal·mol^−1^ Δ*E* + ZPE energy range.(4)The calculated most stable conformer by all DFT levels corresponds to A1, while by MP2 is B2. In the nitrogen atoms and in the O2\' and O5\' oxygen atoms of conformer A1 appear a higher reactivity than in the corresponding natural nucleoside deoxyguanosine.(5)The distribution of all the conformers according to the ranges of stability of the characteristic torsional angles was established. The values obtained indicate the flexible nature of ACV, which is higher than dG. An increase of the stability appears when the side chain is near to the purine base, with a value of R that fails into 3.925--2.892 Å range, and an angle Φ close to 54°.(6)Only two intramolecular H-bonds may be observed in the main conformers of ACV, in contrast to the six H-bond types calculated in dG. It leads to a flexibility higher in ACV than in dG.(7)The solid state was simulated through a dimer and tetramer forms. An excellent agreement with the X-ray crystal data was obtained, which indicates the good accuracy of the theoretical methods used.
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